Admission Date:  [**2195-5-6**]              Discharge Date:   [**2195-5-8**]

Date of Birth:  [**2115-11-6**]             Sex:   F

Service: MEDICINE

Allergies:
Erythromycin Base / Sulfa (Sulfonamide Antibiotics) /
clindamycin

Attending:[**First Name3 (LF) 3918**]
Chief Complaint:
Melena

Major Surgical or Invasive Procedure:
Capsule endoscopy

History of Present Illness:
79 year female with hx of recurrent BRBPR secondary to cecal
AVMs while thrombocytopenic, MDS transformed to AML now day 2
cycle 3 of decitabine therapy p/w melena. The pt has an
extensive history of hematochezia and melena in the setting of
low platelets and cecal AVM bleeds, most recently in the end of
[**Month (only) 958**]. She reports that on Sunday she had significant PO intake
and dietary indiscretions with subsequent abdominal cramping and
diarrhea. She denied hematochezia at the time, though stated the
cramping/diarrhea felt similar to bleeds she had had in the
past. On Tuesday the pt initiated cycle 3 of decitabine.
Overnight she noted significant nightsweats soaking the
bedsheets and mattress, with increased fatigue this morning.
This morning she also experienced one black, sticky bowel
movement, without noticable odor. She endorsed some crampy
abdominal pain but denied lightheadedness, dizziness, sob, cp.
She denies n/v, hematochezia. She presented to BMT for day 2 of
decitabine and was subsequently directly admitted from clinic to
the MICU for concern re: GI bleed.
.
On arrival to the ICU, the pt was hemodynamically stable, with
HR 70s-80s and SBPs in the 110s. She endorsed fatigue and crampy
abdominal pain, but denied other symptoms.
.
Review of systems:
(+) Per HPI
(-) Denies fever, chills, recent weight loss or gain. Denies
headache, sinus tenderness, rhinorrhea or congestion. Denies
cough, shortness of breath, or wheezing. Denies chest pain,
chest pressure, palpitations, or weakness. Denies nausea,
vomiting, constipation. Denies dysuria, frequency, or urgency.
Denies arthralgias or myalgias. Denies rashes or skin changes.

Past Medical History:
- diverticulosis complicated by bleeding
- bleeding anal fissures
- bleeding AVMs ([**2-/2195**])
- GERD
- emphysema(mild)
- dental extraction
- myelodysplastic syndrome dx [**8-/2194**] with persistent blastemia
- hysterectomy at age 39
- hemorrhoidectomy x 4
- colon polyps, AVM
- bilateral bunion surgery
- hypertension
- hyperlipidemia
- proctalgia fugax
- TMJD

Social History:
The patient is married and lives with her husband.  She has
three grown children.  Has a twin sister who lives 5 houses down
from her.  Ex-[**Year (4 digits) 1818**], quit 14 year ago; has 35 pack year
history.  Denies any illicit drug use.


Family History:
No known fhx of MDS or leukemia.

Physical Exam:
ADMISSION EXAM:
Gen: A&Ox3, NAD
CV: rrr nl s1s2
Lungs: CTAB
Ab: ntnd, mild discomfort in the lower quadrants
Ext: no edema
Skin: no petechiae
Rectal: dark brown stool, guiaic+
.
DISCHARGE EXAM:
Vitals: T: 98 BP: 129/52 P: 98 HR 75 R:16 O2: 98RA
General: Alert, oriented, no acute distress
HEENT: Sclera anicteric, MMM, oropharynx clear
Neck: supple, JVP not elevated, no LAD
Lungs: Clear to auscultation bilaterally, no wheezes, rales,
rhonchi
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs,
gallops
Abdomen: soft, non-tender, non-distended, bowel sounds present,
no rebound tenderness or guarding, no organomegaly; capsule
endoscopy pack present
GU: no foley
Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or
edema
Neuro: no focal deficits
Psych: calm, cooperative


Pertinent Results:
ADMISSION LABS:
[**2195-5-6**] 09:20AM BLOOD WBC-8.1 RBC-2.74* Hgb-8.0* Hct-26.3*
MCV-96 MCH-29.3 MCHC-30.5* RDW-17.8* Plt Ct-740*
[**2195-5-6**] 09:20AM BLOOD Neuts-47* Bands-0 Lymphs-17* Monos-0
Eos-0 Baso-0 Atyps-0 Metas-0 Myelos-0 Blasts-36*
[**2195-5-6**] 05:30PM BLOOD WBC-7.4 RBC-2.30* Hgb-7.0* Hct-21.9*
MCV-95 MCH-30.6 MCHC-32.1 RDW-18.0* Plt Ct-675*
[**2195-5-6**] 09:20AM BLOOD Hypochr-2+ Anisocy-2+ Poiklo-NORMAL
Macrocy-2+ Microcy-NORMAL Polychr-1+
[**2195-5-6**] 11:17PM BLOOD PT-15.0* INR(PT)-1.4*
[**2195-5-6**] 11:17PM BLOOD Glucose-101* UreaN-17 Creat-0.8 Na-139
K-4.4 Cl-102 HCO3-29 AnGap-12
[**2195-5-6**] 11:17PM BLOOD Calcium-8.2* Phos-4.5 Mg-2.4
.
Discharge Labs:

[**2195-5-8**] 05:05AM BLOOD WBC-8.6 RBC-3.88* Hgb-11.4* Hct-36.0#
MCV-93 MCH-29.4 MCHC-31.7 RDW-17.8* Plt Ct-864*
[**2195-5-6**] 09:20AM BLOOD Neuts-47* Bands-0 Lymphs-17* Monos-0
Eos-0 Baso-0 Atyps-0 Metas-0 Myelos-0 Blasts-36*
[**2195-5-8**] 05:05AM BLOOD Plt Ct-864*
[**2195-5-8**] 05:05AM BLOOD PT-14.3* PTT-35.4 INR(PT)-1.3*
[**2195-5-8**] 05:05AM BLOOD Glucose-93 UreaN-18 Creat-0.9 Na-136
K-3.9 Cl-97 HCO3-27 AnGap-16
[**2195-5-8**] 05:05AM BLOOD Calcium-8.8 Phos-4.7* Mg-2.3
.


Brief Hospital Course:
Primary Reason for Admission: 79 year old female with hx of
recurrent BRBPR secondary to cecal AVMs, MDS transformed to AML
now day 2 cycle 3 of decitabine therapy p/w melena.
.
Active Problems:
.
# Melena: The pt has an extensive hx of GI bleeds from cecal
AVMs in the setting of thrombocytopenia. On admission to the ICU
she had plts in the 600-700s, however presents with an episode
of melena. Though she remains hemodynamically stable, her HCT
decreased from 26 to 21, concerning for GI bleed. Pt received 2u
pRBC with appropriate bump in HCT. She was also started on IV
PPI. Cauterization was considered, but no endoscopy was
performed as she was hemodynamically stable without evidence of
active bleed. Capsule endoscopy was performed, the results of
which were pending at the time of discharge.
.
# MDS with AML transformation: Day of admission was day 2 of
cycle 3 decitabine. Decitabine was held in setting of GI bleed.
This will be continued per her outpatient Oncologist.
.
Transitional Issues: Ms [**Known lastname 73078**] will be contact[**Name (NI) **] with the
results of her Capsule Endoscopy once complete. Depending on the
findings, GI will dictate further workup and/or intervention.
She will f/u with Heme/Onc [**2195-5-12**].



Medications on Admission:
omeprazole
ondansetron HCl
polyethylene glycol 3350 17 gram
docusate sodium
loratadine
magnesium hydroxide [Milk of Magnesia]
multivit-mineral-iron-lutein [Centrum Silver Ultra Women's]
Chemo: Decitabine

Discharge Medications:
1. omeprazole 20 mg Tablet, Delayed Release (E.C.) Sig: One (1)
Tablet, Delayed Release (E.C.) PO once a day.
2. Zofran 8 mg Tablet Sig: One (1) Tablet PO every eight (8)
hours as needed for nausea.
3. polyethylene glycol 3350 17 gram Powder in Packet Sig: One
(1)  PO once a day as needed for constipation.
4. loratadine 10 mg Tablet Sig: One (1) Tablet PO daily ().
5. Milk of Magnesia 400 mg/5 mL Suspension Sig: Thirty (30) mL
PO at bedtime.
6. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO twice
a day.


Discharge Disposition:
Home

Discharge Diagnosis:
Primary Diagnosis:
GI Bleeding
Secondary Diagnosis:
MDS with transformation to AML
Diverticulosis
Cecal AVMs


Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.


Discharge Instructions:
Dear Ms [**Known lastname 73078**],

It was a pleasure caring for you at the [**Hospital1 827**]. You were admitted for bleeding and were given
blood transfusions in the ICU. You had a capsule endoscopy, the
results of which are pending at this time. You blood counts
improved appropriately and given you are not having active
bleeding, we feel you are now safe to return home.

We made no changes to your medications on this admission.

Followup Instructions:
You will be contact[**Name (NI) **] by Dr [**First Name8 (NamePattern2) **] [**Name (NI) **] regarding the results
of your capsule endoscopy on Monday [**5-11**]. If you do not receive
a phone call from Dr. [**Last Name (STitle) **], please call [**Telephone/Fax (1) 463**] and ask
for her by name.

Department: BMT/ONCOLOGY UNIT
When: TUESDAY [**2195-5-12**] - we will call you with the time
Building: SC [**Hospital Ward Name 23**] Clinical Ctr [**Location (un) **]
Campus: EAST     Best Parking: Main Garage


                             [**Name6 (MD) **] [**Name8 (MD) **] MD [**MD Number(2) 392